Deepak Nitrite Ltd

- For the upcoming polycarbonate project, financial arrangements and funding tie-ups are at the final stage, ensuring readiness from both capital and balance sheet perspectives (Page 6). - The company is progressing with strategic growth initiatives and capital allocation firmly anchored to long-term priorities, including accelerated investments across multiple high-impact growth platforms (Page 6). - CAPEX outlay guidance: - FY26: Approximately INR 100 crore already underway. - FY27: Estimated CAPEX of around INR 2,500 crore (Page 19). - No explicit mention of new fundraising through debt or equity in the transcript. - The company's balance sheet remains robust with strong financial flexibility to support future growth and expansion, suggesting current funding needs are managed prudently (Page 6, Page 19).

- CAPEX for FY27 is around INR 2,500 crore; FY26 spend is around INR 100 crore with a total of approximately INR 1,200–1,300 crore underway. - Medium-scale investment in Dahej for agrochemicals with a world's first process aimed at unmatched carbon footprint, cost, and product quality; ramp-up starting October 2026 into calendar year 2027. - Polycarbonate project on track for commissioning by December 2027, involving site dismantling in Germany and construction in Dahej; this project expected to diversify revenue and improve margins. - New product pipeline includes about 15 products across R&D, piloting, and customer validation, focusing on mining chemicals, flame retardants, personal care, flavors & fragrances, and polymer applications; staggered commercialization expected in FY27. - Strategic investment of about INR 100 crore in R&D facilities, focusing on innovation rather than operating asset utilization. - Ongoing debottlenecking efforts to improve capacity utilization in existing plants.

- Advanced Intermediates (AI) segment expects volume growth around 20% YoY, with focus on maintaining market presence and optimizing pricing post upstream integration (Q3 FY26 discussion). - New product pipeline includes about 15 products targeting mining chemicals, flame retardants, personal care, flavors & fragrances, and polymer applications, with staggered commercial launches anticipated in the next several months (FY27). - MIBK/MIBC project targeted for commissioning by Q4 FY26, with revenue contribution expected from Q1 FY27 onwards. - Polycarbonate project on track for commissioning around December 2027, expected to diversify revenue streams. - Phenolics segment showing strong utilization and margin expansion with scope for further debottlenecking. - Medium-scale agrochemical investment at Dahej expected to ramp up supplies from October (CY27), contributing to revenue growth. - Overall, cautious optimism on demand recovery and margin normalization in Q4 FY26 and beyond, despite global oversupply challenges.

- Deepak Nitrite expects improved margins and revenue diversification with new product launches and capacity expansions, including the fully integrated aromatic-to-amine value chain and polycarbonate project. - Ramp-up of new assets (nitration, hydrogenation, nitric acid plants) underway; target utilization near 100% from current quarter onwards. - Medium-term CAPEX of around INR 2,500 crore planned for FY27 to drive growth. - Operational leverage and process optimizations have already improved EBITDA by 16% YoY in Q3 FY26, despite pricing pressures. - Margin recovery anticipated in Q4 FY26 driven by integration benefits and easing global supply pressures. - Continued focus on specialty product expansions, geographic expansion, and sustainable practices expected to drive long-term profitable growth. - Cautious optimism due to global volatility, but integrated operations and cost leadership position the company for sustained EPS growth over coming years.

The transcript from the February 13, 2026 earnings call for Deepak Nitrite Limited does not explicitly mention the current or expected order book or pending orders in specific terms. However, some relevant insights related to orders and demand include: - Advanced Intermediates (AI) segment experienced subdued performance due to pricing pressure and market softness, partly self-inflicted by aggressive market placement (Page 20). - The company has a pipeline of about 15 new products in various stages of R&D and customer validation, expected to come to market in a staggered manner over the next several months, indicating potential future order inflows (Page 7). - The company is working on improving market presence and optimizing pricing following upstream integration, indicating active efforts to maintain and grow order volumes (Page 20). - There are favorable signs of improvement in demand in sectors like dyes, pigments, mining chemicals, explosives, polymers, food, and pharmaceuticals (Page 15). - Capacity ramp-ups and commissioning of new assets (e.g., fluorination unit coming online Q1 FY27) suggest readiness to fulfill increased orders (Page 20). No direct numerical order book or pending orders data is provided.